- Home
- OCC vs BCLI Comparison
OCC vs BCLI Comparison
Compare OCC & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- BCLI
- Stock Information
- Founded
- OCC 1983
- BCLI 2000
- Country
- OCC United States
- BCLI United States
- Employees
- OCC N/A
- BCLI N/A
- Industry
- OCC Telecommunications Equipment
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OCC Industrials
- BCLI Health Care
- Exchange
- OCC Nasdaq
- BCLI Nasdaq
- Market Cap
- OCC 21.8M
- BCLI 25.0M
- IPO Year
- OCC 1996
- BCLI N/A
- Fundamental
- Price
- OCC $2.55
- BCLI $2.43
- Analyst Decision
- OCC
- BCLI Strong Buy
- Analyst Count
- OCC 0
- BCLI 1
- Target Price
- OCC N/A
- BCLI $30.00
- AVG Volume (30 Days)
- OCC 9.4K
- BCLI 77.4K
- Earning Date
- OCC 09-11-2024
- BCLI 11-12-2024
- Dividend Yield
- OCC N/A
- BCLI N/A
- EPS Growth
- OCC N/A
- BCLI N/A
- EPS
- OCC N/A
- BCLI N/A
- Revenue
- OCC $64,517,697.00
- BCLI N/A
- Revenue This Year
- OCC N/A
- BCLI N/A
- Revenue Next Year
- OCC N/A
- BCLI N/A
- P/E Ratio
- OCC N/A
- BCLI N/A
- Revenue Growth
- OCC N/A
- BCLI N/A
- 52 Week Low
- OCC $2.43
- BCLI $1.95
- 52 Week High
- OCC $3.53
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- OCC 45.30
- BCLI 36.93
- Support Level
- OCC $2.43
- BCLI $1.97
- Resistance Level
- OCC $2.75
- BCLI $2.24
- Average True Range (ATR)
- OCC 0.09
- BCLI 0.37
- MACD
- OCC -0.00
- BCLI 0.03
- Stochastic Oscillator
- OCC 37.50
- BCLI 26.26
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, broadcast, oil & gas, and others.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.